PTAB Approves Kyle Bass' 2nd Bid To Review MS Drug Patent
The Patent Trial and Appeal Board ordered an inter partes review Tuesday of Biogen MA Inc.'s patent covering multiple sclerosis drug Tecfidera, saying prior art newly submitted by an organization tied...To view the full article, register now.
Already a subscriber? Click here to view full article